Abstract
Although the importance of animal cell culture for the industrial (large scale) production of pharmaceutical products is continuously increasing, the sensibility of the cells towards their cultivation environment is still a challenging issue. In comparison to microbial cultures, cell cultures which are not protected by a cell wall are much more sensitive to shear stress and foam formation. Reactor design as well as the selection of ‘robust’ cell lines is particularly important for these circumstances. Nevertheless, even ‘sensitive’ cell lines are selected for certain pharmaceutical processes due to various reasons. These sensitive cell lines have even higher requirements regarding their cultivation environment. Important characteristics for the corresponding reactor design are a high (volumetric) gas mass transfer coefficient, low volumetric power input, low shear stress, low susceptibility to bio-fouling, the ability to cultivate sticky cells and sufficient mixing properties. Membrane aeration has been a long-known possibility to meet some of these requirements, but has not often been applied in recent years. The reasons lie mainly in low gas mass transfer rates, a limited installable volume-specific membrane surface area, restrictions in scalability and problems with membrane fouling. The dynamic membrane aeration bioreactor aeration is a simple concept for bubble-free oxygen supply of such sensitive cultures. It overcomes limitations and draw-backs of previous systems. Consisting of an oscillating, centrally arranged rotor (stirrer) that is wrapped with silicone membrane tubing, it enables doubling the gas mass transfer at the same shear stress in the investigated cultivation scales of 12, 20, 100, and 200 L. Continuous cultivation at these scales allows the same product output as fed-batch cultivation does at tremendously larger reactor volumes. Apart from introducing this novel technology, the presentation comprises selected cultivation results obtained for blood coagulation factor VIII in continuous mode and a therapeutic monoclonal antibody in fed-batch mode in comparison to reference trials.
Similar content being viewed by others
Abbreviations
- a :
-
Fermenter liquid volume-specific membrane surface area (m2 m−3)
- d ef :
-
Equivalent floc diameter (μm)
- k :
-
(Oxygen) mass transfer coefficient (m h−1)
- ka :
-
Volume-specific (oxygen) mass transfer coefficient (h−1)
- P :
-
Power input (W)
- P/V :
-
Volume-specific power input (W m−3)
- V :
-
Fermenter (liquid) volume (m3)
References
Ahmed T, Semmens MJ (1992a) The use of independently sealed microporous hollow fiber membranes for oxygenation of water: model development. J Membr Sci 69:11–20
Ahmed T, Semmens MJ (1992b) Use of sealed end hollow fibres for bubbleless membrane aeration: experimental studies. J Membr Sci 69:1–10
Ahmed T, Semmens MJ (1996) Use of transverse flow hollow fibers for bubbleless membrane aeration. Water Res 30:440–446
Ahmed T, Semmens MJ, Voss MA (2004) Oxygen transfer characteristics of hollow-fiber, composite membranes. Adv Environ Res 8:637–646
Aunins JG, Croughan MS, Wang DIC (1986) Engineering developments in homogeneous culture of animal cells: oxygenation of reactors and scale-up. Biotechnol Bioeng Symp 17:699–723
Aunins JG, Henzler HJ (1993) Aeration in Cell Culture Bioreactors. In: Biotechnology, Second, Completely Revised Edition, Volume 3: Bioprocessing: 219–281, VCH Wiley
Birch JR, Thompson PW, Boraston R, Oliver S, Lambert K (1987) The large-scale production of monoclonal antibodies in airlift fermenters. In: Webb C, Mavituna F (eds) Plant and animal cells: process possibilities. Ellis Horwood, Chichester, pp 162–171
Catapano C, Hornscheidt R, Wodetzki A, Baurmeister U (2004) Turbulent flow technique for the estimation of oxygen diffusive permeability of membranes fort the oxygenation of blood and other cell suspensions. J Membr Sci 230:131–139
Chisti Y (2000) Animal-cell damage in sparged bioreactors. TIBTECH 18:420–432
Chu L, Robinson DK (2001) Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol 12:180–187
Côté P, Bersillon JL, Huyard A, Faup G (1988) Bubble-free aeration using membranes: process analysis. J Water Pollut Control Fed 60:1986–1992
Côté P, Bersillon JL, Huyard A (1989) Bubble-free aeration using membranes: mass transfer analysis. J Membr Sci 47:91–108
Engasser JM (1988) Bioreactor engineering: the design and optimization of reactors with living cells. Chem Eng Sci 43:1739–1748
Farid SS (2006) Cell established bioprocesses for producing antibodies as a basis for future planning. Adv Biochem Engin/Biotechnol 101:1–42
Fenge C, Lüllau E (2006) Cell culture bioreactors. In: Ozturk SS, Hu WS (eds) Cell culture technology for pharmaceutical and cell-based therapies. Taylor & Francis, New York, pp 155–224
Frahm B, Kirchner S, Kauling J, Brod H, Langer U, Bödeker B (2007) Dynamische Membranbegasung im Bioreaktor zur Intensivierung der Sauerstoffversorgung empfindlicher Zelllinien. Chem Ing Tech 79:1052–1058
Henzler HJ (1978) Untersuchungen zum Homogenisieren von Flüssigkeiten und Gasen. VDI-Forschungsheft 587:7
Henzler HJ (2000) Particle stress in bioreactors. Adv Biochem Eng/Biotechnol 67:35–82
Henzler HJ, Kauling J (1993) Oxygenation of cell cultures. Bioprocess Eng 9:61–75
Henzler HJ, Obernosterer G (1991) Effect of mixing behaviour on gas–liquid mass transfer in highly viscous, stirred non-newtonian liquids. Chem Eng Technol 14:1–10
Katinger HWD, Schreier W, Krömer E (1997) Bubble column reactor for mass propagation of animal cells in suspension culture. Ger Chem Eng 2:31
Kim HK, Ham MS, Hong JS, Lee JH, Park KY, Lee HY (1996) Use of moving aeration membrane bioreactor for the efficient production of tissue type plasminogen activator in serum free medium. Biotechnol Bioprocess Eng 1:32–35
Kompala DS, Ozturk SS (2006) Optimization of high cell density perfusion bioreactors. In: Ozturk SS, Hu WS (eds) Cell culture technology for pharmaceutical and cell-based therapies. Taylor & Francis, New York, pp 387–416 (2005)
Lehmann J (1989) European patent 0172478
Lehmann J, Piehl GW, Schulz R (1987) Bubble-free cell culture aeration with porous moving membranes. Develop Biol Standard 66:227–240
Ma N, Chalmers JJ, Aunins JG, Zhou W, Xie L (2004) Quantitative studies of cell-bubble interactions and cell damage at different pluronic F-68 and cell concentrations. Biotechnol Progr 20:1183–1191
Mahnke EU, Büscher K, Hempel DC (2000) A novel approach for the determination of mechanical stresses in gas-liquid reactors. Chem Eng Technol 23:509–513
Mayr B (1992) Engineering approach to mixing quantification in bioreactors. Bioprocess Eng 8:137–143
Murhammer DW, Goochee CF (1990) Sparged animal cell bioreactors: mechanism of cell damage and pluronic F-68 protection. Biotechnol Progr 6:391–397
Nehring D, Czermak P, Vorlop J, Lübben H (2004) Experimental study of a ceramic microsparging aeration system in a pilot-scale. Biotechnol Progr 20:1710–1717
Oldshue Y (1996) Fermentation mixing scale up techniques. Biotechnol Bioeng 8:3–24
Qi H, Jovanovic GN, Michaels JD, Konstantinov KB (2001) The art and science of micro-sparging in high-density perfusion cultures of animal cells. In: Linder-Olsson E, Chatzissavidou N, Lüllau E (eds) Animal cell technology: from target to market. Kluwer Academic Publishers, Dordrecht, pp 412–415
Qi HN, Goudar CG, Michaels JD, Henzler HJ, Jovanovic GN, Konstantinov KB (2003) Experimental and theoretical analysis of tubular membrane aeration for mammalian cell bioreactors. Biotechnol Progr 19:1183–1189
Schneider M, Reymond F, Marison IW, von Stockar U (1995) Bubble-free oxygenation by means of hydrophobic porous membranes. Enzyme Microb Technol 17:839–847
Su WW, Caram HS, Humphrey AE (1992) Optimal design of the tubular microporous membrane aerator for shear sensitive cell cultures. Biotechnol Progr 8:19–24
Sucker HG, Jordan M, Eppenberger HM, Widmer F (1994) Bubble bed reactor: a reactor design to minimize the damage of bubble aeration on animal cells. Biotechnol Bioeng 44:1246–1254
Vorlop J, Lehmann J (1988) Scale-up of bioreactors for fermentation of mammalian cell cultures, with special reference to oxygen supply and microcarrier mixing. Chem Eng Technol 11:171–178
Acknowledgments
This development of the DMA was funded by Bayer Technology Services (BTS) within two consecutive research projects. We would like to thank to Messrs. Rose, Gießelmann, and Grodotzki for carrying out the reactor design drawings and to colleagues form Tectrion for manufacturing the reactors (Messrs Commer, Schiffczyk, Drinhausen, Kamphusmann, and Letzner). We wish to thank our colleagues in the Enzyme & Fermentation Technology group of BTS for their support. We express our gratitude to the students Andreas Sinthern, Juliane Schröter, and Maike Rampe for their contributions made in the context of their diploma theses. The described fed-batch cell cultivations with the 20 and 200 L bioreactors took place on the premises of Bayer Health Care AG in Wuppertal. For this, special thanks are due to Mr. Wischniewski and his colleagues. The continuous cell cultivations with the 12 L bioreactors were performed at Bayer Health Care in Berkeley, USA. Special thanks for this to Klaus Jöris and his colleagues.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frahm, B., Brod, H. & Langer, U. Improving bioreactor cultivation conditions for sensitive cell lines by dynamic membrane aeration. Cytotechnology 59, 17–30 (2009). https://doi.org/10.1007/s10616-009-9189-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-009-9189-9